References

1. Ciombor KK, Wu C, Goldberg RM (2015) Recent therapeutic advances in the treatment of colorectal cancer. Annual review of medicine 66: 83-95. View
2. Bouvier AM, Launoy G (2015) [Epidemiology of colorectal cancer]. La Revue du praticien 65: 767-773.
3. Kallay E, Wrba F, Cross HS (2003) Dietary calcium and colon cancer prevention. Forum of nutrition 56: 188-190. View
4. Haga E, Endo Y, Haruta M, Koba C, Matsumura K, et al. (2014) Therapy of peritoneally disseminated colon cancer by TAP-deficient embryonic stem cell-derived macrophages in allogeneic recipients. Journal of immunology 193: 2024-2033. View
5. Knoop K, Schwenk N, Schmohl K, Muller A, Zach C, et al. (2015) Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 56: 600-606. View
6. Maillet M, Glehen O, Lambert J, Goere D, Pocard M, et al. (2015) Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study. Ann Surg Oncol. View
7. Zhang SD, McCrudden CM, Meng C, Lin Y, Kwok HF (2015) The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab. Onco Targets and Therapy 8: 835-843. View